Infectious Diseases News and Research

RSS

Race and income impacts rate of bystander-initiated CPR in communities

Individuals who have an out-of-hospital cardiac arrest are most likely to receive bystander-initiated cardiopulmonary resuscitation if they live in a predominantly White, high-income neighborhood, study results show.

30 Oct 2012

Exercise not to blame for sudden cardiac death

Exercise is not to blame for sudden cardiac death in young and seemingly fit people, say researchers.

29 Oct 2012

Sedation interruption does not reduce mechanical ventilation duration

Daily sedative interruption of mechanically ventilated patients in intensive care units does not reduce the time they are on ventilation or improve their clinical outcomes, report researchers in JAMA.

29 Oct 2012

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet.

29 Oct 2012

Scientists hope to unravel mystery of how Borrelia burgdorferi causes Lyme disease

Investigators at The University of Texas Health Science Center at Houston (UTHealth) have accelerated the search for the bacterial genes that make the Lyme disease bacterium so invasive and persistent. The discovery could advance the diagnosis and treatment of this disease, which affects an estimated 30,000 Americans each year.

29 Oct 2012

TB testing: today as good as 2-day

Same-day sputum smear microscopy is as effective as standard smear microscopy for the detection of pulmonary tuberculosis, according to a review commissioned by the World Health Organization.

26 Oct 2012

Universal approach to MRSA-prevention in ICU is most effective

Universal decolonization of all patients admitted to intensive care units using chlorhexidine baths and mupirocin treatment for 5 days significantly reduces the risk for infection with methicillin-resistant Staphylococcus aureus , report researchers.

26 Oct 2012

Loyola and Hines VA announce accreditation of Dermatopathology Fellowship Program by ACGME

Loyola University Chicago Stritch School of Medicine and the Edward Hines, Jr. VA Hospital Pathology and Dermatology Divisions have announced the accreditation of a Dermatopathology Fellowship Program by the Accreditation Council for Graduate Medical Education (ACGME).

26 Oct 2012

Researchers figure out 3D shape of promising TB drug target

Researchers at Johns Hopkins have figured out the three-dimensional shape of the protein responsible for creating unique bonds within the cell wall of the bacteria that cause tuberculosis. The bonds make the bacteria resistant to currently available drug therapies, contributing to the alarming rise of these super-bacteria throughout the world.

26 Oct 2012

Allergies and hygiene: an interview with Sally Bloomfield

Allergies occur when the body overreacts to substances in our environment, such as pollen, dust mites and so forth. What happens is that when we are exposed to these potential threats, the immune system should react, deal with it, and then shut down.

26 Oct 2012

Simple approach results in low rates of MRSA infections

High compliance with hand hygiene and focusing on other simple infection control measures on medical, surgical and neuroscience intensive care units resulted in reduced rates of methicillin-resistant Staphylococcus aureus (MRSA) infection by 95 percent in a nine-year study, according to research findings by Virginia Commonwealth University physicians presented during IDWeek 2012.

26 Oct 2012

Durata completes target enrollment in dalbavancin Phase 3 trial for ABSSSI

Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 2 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), the second global, Phase 3 clinical trial of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria.

26 Oct 2012

Global Health Service Partnership 'could be the start of something big'

Writing in GlobalPost's "Global Pulse" blog, Claire Panosian Dunavan, a professor of medicine and infectious diseases at the University of California, Los Angeles, reflects on the Global Health Service Partnership, a new public-private partnership launched by Vanessa Kerry, daughter of Sen. John Kerry (D-Mass.) "to boost the education of doctors and nurses in sub-Saharan Africa."

25 Oct 2012

Communicable diseases responsible for majority of deaths in Africa, WHO official says

Speaking on Monday in Luanda, Angola, at the opening session of the inaugural meeting on Medical Education, sponsored by the Faculty of Medicine of Agostinho Neto University, WHO Regional Director for Africa Luis Gomes Sambo said communicable diseases account for 63 percent of deaths in Africa, with HIV and tuberculosis (TB) responsible for the majority of those, the Angola Press reports.

25 Oct 2012

BioLineRx intends to conduct interim analysis of BL-1020 Phase II/III trial for schizophrenia

BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.

25 Oct 2012

Scientists unravel physical properties of lung mucus

Mucus coats our airways' internal surfaces. The viscous gel humidifies the lungs and prevents viruses and other small particles like diesel soot from entering the body unchecked. Previously unclear was the extent to which such nanoparticles are able to move through the lungs' mucus. Here, the research evidence was contradictory. Scientists could not explain why, in inhaled medication development, drug nanoparticles often simply got stuck in the mucus never making it to their target destination inside the lung cells.

25 Oct 2012

New method of testing for West Nile virus

While the United States has largely been spared the scourge of mosquito-borne diseases endemic to the developing world-including yellow fever, malaria and dengue fever-mosquito-related illnesses in the US are on the rise. One pathogen of increasing concern in the U.S. is an arbovirus known as West Nile.

24 Oct 2012